French advanced visualization firm Intrasense is displaying new artificial intelligence (AI) applications for lung and brain imaging in collaboration with partners 12 Sigma Technologies and Quantib at RSNA 2018.
With 12 Sigma, the company has developed Discover Lung for detection and thin segmentation of lung nodules.
The company's partnership with Quantib features a neurology imaging application called Quantib ND for analyzing brain MRI studies.
Intrasense's Myrian visualization software also is being presented in a prostate MRI workshop at this year's RSNA meeting, as it was in 2017.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
